Disc Medicine Shares Polycythemia Vera Data, Outlines Late 2026 Trial Milestones

기사 요약

Disc Medicine says Phase 2 RESTORE-PV data shows DISC-3405 reduces phlebotomy needs and controls hematocrit in polycythemia vera patients.